Evidence map›Paper›PMID 35148199›Full record

ArticleScience immunology2022

SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.

Daimon P Simmons, Hung N Nguyen, Emma Gomez-Rivas, Yunju Jeong, A Helena Jonsson, Antonia F Chen, Jeffrey K Lange, George S Dyer, Philip Blazar, Brandon E Earp and 8 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. A mechanically compliant SrTiOMaterials today. Bio · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. iScience · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Daimon P SimmonsDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0003-1429-4073
Hung N NguyenHarvard Medical School, Boston, MA, USA.
Emma Gomez-RivasDivision of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Yunju JeongHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-0453-3475
A Helena JonssonHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-9558-2474
Antonia F ChenHarvard Medical School, Boston, MA, USA.ORCID 0000-0003-2040-8188
Jeffrey K LangeHarvard Medical School, Boston, MA, USA.
George S DyerHarvard Medical School, Boston, MA, USA.ORCID 0000-0003-2734-9213
Philip BlazarHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-2156-0053
Brandon E EarpHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-7983-3325
Jonathan S CoblynHarvard Medical School, Boston, MA, USA.
Elena M MassarottiHarvard Medical School, Boston, MA, USA.
Jeffrey A SparksHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-5556-4618
Derrick J ToddHarvard Medical School, Boston, MA, USA.ORCID 0000-0003-2290-2235
Accelerating Medicines Partnership (AMP) RA/SLE Network
Deepak A RaoHarvard Medical School, Boston, MA, USA.ORCID 0000-0001-9672-7746
Edy Y KimHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-9095-3109
Michael B BrennerHarvard Medical School, Boston, MA, USA.ORCID 0000-0001-6202-8445
Brigham and Women's Hospital · US

Funding

Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLEP01AI148102 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nir Hacohen · 2021 to 2026
$17.3M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
PEARL: Pathway Exploration and Analysis in Renal LupusUH2AR067688 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DIAMOND, BETTY, WOFSY, DAVID · 2014 to 2020
$9.0M
Tissue Acquisition Research GroupUM2AR067678 · NIAMS · STANFORD UNIVERSITY · PI HOLERS, VERNON MICHAEL, UTZ, PAUL JOSEPH · 2014 to 2020
$8.2M
Multi-Ethnic Translational Research Optimization (METRO) Lupus ConsortiumUH2AR067689 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P, PUTTERMAN, CHAIM · 2014 to 2020
$6.3M
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established DiseaseUH2AR067681 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2014 to 2020
$5.5M
Molecular and Cellular Dissection of Early Rheumatoid ArthritisUH2AR067694 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI BRENNER, MICHAEL B., GREGERSEN, PETER K. · 2014 to 2020
$5.4M
RA-SLE Molecular Deconstruction Leadership CenterUH2AR067677 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B., RAYCHAUDHURI, SOUMYA · 2014 to 2020
$4.3M
Cellular Dynamics at the Synovium-Bone interface in RAUH2AR067690 · NIAMS · UNIVERSITY OF ROCHESTER · PI ANOLIK, JENNIFER HOWITT · 2014 to 2020
$3.0M
Stanford Technology Accelerating Medicines Partnership CenterUH2AR067676 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H, UTZ, PAUL JOSEPH · 2014 to 2020
$2.6M
Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)UH2AR067679 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 2014 to 2020
$2.1M
NHLBI NIH HHS T32 HL007627NIAID NIH HHS P01 AI148102NIAMS NIH HHS K08 AR075850NIAMS NIH HHS P30 AR070253NIAMS NIH HHS UH2 AR067676NIAMS NIH HHS UH2 AR067677NIAMS NIH HHS UH2 AR067679NIAMS NIH HHS UH2 AR067681NIAMS NIH HHS UH2 AR067685NIAMS NIH HHS UH2 AR067688NIAMS NIH HHS UH2 AR067689NIAMS NIH HHS UH2 AR067690NIAMS NIH HHS UH2 AR067691NIAMS NIH HHS UH2 AR067694NIAMS NIH HHS UM2 AR067678
6 · The paper itself

Abstract

Macrophages regulate protective immune responses to infectious microbes, but aberrant macrophage activation frequently drives pathological inflammation. To identify regulators of vigorous macrophage activation, we analyzed RNA-seq data from synovial macrophages and identified SLAMF7 as a receptor associated with a superactivated macrophage state in rheumatoid arthritis. We implicated IFN-γ as a key regulator of SLAMF7 expression and engaging SLAMF7 drove a strong wave of inflammatory cytokine expression. Induction of TNF-α after SLAMF7 engagement amplified inflammation through an autocrine signaling loop. We observed SLAMF7-induced gene programs not only in macrophages from rheumatoid arthritis patients but also in gut macrophages from patients with active Crohn's disease and in lung macrophages from patients with severe COVID-19. This suggests a central role for SLAMF7 in macrophage superactivation with broad implications in human disease pathology.

Indexed as

Acute DiseaseAdultArthritis, RheumatoidCells, CulturedChronic DiseaseCOVID-19Crohn DiseaseFemaleHumansInflammationMacrophage ActivationReverse Transcriptase Polymerase Chain ReactionRNA-SeqSARS-CoV-2Signaling Lymphocytic Activation Molecule FamilySingle-Cell AnalysisSignaling Lymphocytic Activation Molecule FamilySLAMF7 protein, human

Identifiers

PMID35148199
PMCPMC8991457
OpenAlexW4221110333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.